ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 301739 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 301739; 2) Community: the network communities that were significantly associated with the response to NSC 301739; 3) Molecule: the relationships between components within communities and NSC 301739; 4) MDR: the compounds that were significantly associated with the NSC 301739.

NSC Compound Enrichment Correlation
NSC 736493 Indenoisoquinoline derivative 0.0420420371076614 0.63232951
NSC 742327 (3-Difluoromethyl-6,7-dimethyl-1,4-dioxy-quinoxalin-2-yl)-phenyl-methanone 0.0420420371076614 0.30269425
NSC 74702 Benzamide, N-[4-(2-anthraquinonylamino)-1-anthraquinonyl]- (8CI) 0.0420420371076614 0.050612574
NSC 758664 Sirolimus [USAN] 0.0420420371076614 0.24090265
NSC 763186 Null 0.0420420371076614 -0.025425777
NSC 94600 Camptothecin 0.0420420371076614 0.65542827
NSC 96996 B 169 0.0420420371076614 0.1015742
NSC 253272 Acetamide, N-[(methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]- (9CI) 0.043472147060915 0.12373339
NSC 657271 (+/-) Ethyl cis-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate 0.0434721470609156 0.087828854
NSC 744023 (11aS)-8-(3-{4-[(E)-3-(2-hydroxyphenyl)-3-oxo-1-propenyl]-2-methoxyphenoxy}propoxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0434721470609156 0.36407433
Total:40  Current:36    [First] [Prev] [Next] [Last]